Reviewer #1 (Public review): Global molecular landscape of early MASLD progression in obesity
Year: 2026
Type: peer-review
Source: eLife
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,500
Funders: McGill University, Diamond Light Source, European Federation of Pharmaceutical Industries and Associations, European Commission, Robert Bosch Stiftung, Stiftelsen för Strategisk Forskning, Cancerfonden, IngaBritt och Arne Lundbergs Forskningsstiftelse, Knut och Alice Wallenbergs Stiftelse, Novo Nordisk, Vetenskapsrådet, Science for Life Laboratory
Awards: G1136200349, Infrastructure to enhance IceCube, G1412116590, G2004031785, G2069020201, Metabolic signaling from the liver in type 2 diabetes, G263730981, G3032835362, G3142454408, G356701962, G3635226478, G3918735012, G4707829565, G523150154, G5263093510, G5307063007, G5412191534, G5497122441, G55242246, G566907453, G5760331781, G579695895, Targeting tissue crosstalk to combat non-alcoholic fatty liver disease, G6244271739, G6456144897, G67379338, G6909515257, G7152249211, LUDC-IRC för individanpassad medicin i diabetes, EUbOPEN: Enabling and Unlocking biology in the OPEN, G7994185269, G8028722525, G8080493566, Targeting adipose tissue-liver cross talk to combat non-alcoholic fatty liver disease, G8965384046
OpenAlex ID: W7131087629